Quarterly report pursuant to Section 13 or 15(d)

Net Income (Loss) per Share (Tables)

v3.23.1
Net Income (Loss) per Share (Tables)
3 Months Ended
Apr. 02, 2023
Earnings Per Share [Abstract]  
Computation of Basic and Dilute Net EPS The following table sets forth the computation of the Company’s basic and diluted net EPS of common stock for the periods presented below (in thousands, except share and per share amount).
Quarters Ended
April 2, 2023 April 3, 2022
Numerator:
Net income (loss) attributable to common stockholders - basic $ (73,603) $ 42,707 
Decrease in fair value of Private Placement Warrants —  (67,800)
Net loss attributable to common stockholders - diluted $ (73,603) $ (25,093)
Denominator:
Weighted-average shares outstanding used in computing net loss per share of common stock, basic 155,626,977  151,648,439 
Dilutive effect of Private Placement Warrants —  1,690,023 
Weighted-average shares outstanding used in computing net loss per share of common stock, diluted 155,626,977  153,338,462 
Net income (loss) per share of common stock:
Basic $ (0.47) $ 0.28 
Diluted $ (0.47) $ (0.16)
Schedule of Anti-Dilutive Securities Excluded From Computation of Diluted Loss Per Share
As the Company reported net loss for the periods presented above, these potentially dilutive securities were anti-dilutive and are excluded in the computation of diluted net loss per share. The following table discloses shares of the securities that were not included in the diluted EPS calculation above because they are anti-dilutive for the periods presented above.
Quarters Ended
April 2, 2023 April 3, 2022
Stock options outstanding 4,608,824  5,536,905 
Restricted stock units and performance restricted stock units outstanding 9,821,622  917,079 
Private Placement Warrants outstanding 6,000,000  — 
Employee stock purchase plan estimated shares 349,988  78,198